KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties.

Abstract:

:Studies have reported that interactions between keratins (KRTs) and other proteins initiate signaling cascades that regulate cell migration, invasion, and metastasis. In the current study, we found that expression of KRT19 was specifically high in breast cancers and significantly correlated with their invasiveness. Moreover, knockdown of KRT19 led to increased proliferation, migration, invasion, drug resistance, and sphere formation in breast cancer cells via an upregulated NOTCH signaling pathway. This was owing to reduced expression of NUMB, an inhibitory protein of the NOTCH signaling pathway. In addition, we found that KRT19 interacts with β-catenin/RAC1 complex and enhances the nuclear translocation of β-catenin. Concordantly, knockdown of KRT19 suppressed the nuclear translocation of β-catenin as well as β-catenin-mediated NUMB expression. Furthermore, modulation of KRT19-mediated regulation of NUMB and NOTCH1 expression led to the repression of the cancer stem cell properties of breast cancer patient-derived CD133high/CXCR4high/ALDH1high cancer stem-like cells (CSLCs), which showed very low KRT19 and high NOTCH1 expression. Taken together, our study suggests a novel function for KRT19 in the regulation of nuclear import of the β-catenin/RAC1 complex, thus modulating the NUMB-dependent NOTCH signaling pathway in breast cancers and CSLCs, which might bear potential clinical implications for cancer or CSLC treatment.

journal_name

Oncogene

journal_title

Oncogene

authors

Saha SK,Choi HY,Kim BW,Dayem AA,Yang GM,Kim KS,Yin YF,Cho SG

doi

10.1038/onc.2016.221

subject

Has Abstract

pub_date

2017-01-19 00:00:00

pages

332-349

issue

3

eissn

0950-9232

issn

1476-5594

pii

onc2016221

journal_volume

36

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • The erythropoietin-receptor pathway modulates survival of cancer cells.

    abstract::Anemia in cancer patients is associated with reduced quality of life and local failure after radiation treatment. However, the use of erythropoietin to correct cancer anemia and to improve radiation efficacy was disappointing. Erythropoietin-receptor signaling mainly acts via activation of STAT 5, but also crossactiva...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208140

    authors: Pajonk F,Weil A,Sommer A,Suwinski R,Henke M

    更新日期:2004-11-25 00:00:00

  • Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.

    abstract::The motility of cancer cells in 3D matrices is of two types: mesenchymal motility, in which the cells are elongated and amoeboid motility, in which the cells are round. Amoeboid motility is driven by an actomyosin-based contractile force, which is regulated by the Rho/ROCK pathway. However, the molecular mechanisms un...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.2

    authors: Yamazaki D,Kurisu S,Takenawa T

    更新日期:2009-04-02 00:00:00

  • Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism.

    abstract::Cancer cells can use a variety of metabolic substrates to fulfill the bioenergetic and biosynthetic needs of their oncogenic program. Besides bioenergetics, cancer cell metabolism also directly influences genetic, epigenetic and signaling events associated with tumor progression. Many cancer cells are addicted to glut...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.364

    authors: Cacace A,Sboarina M,Vazeille T,Sonveaux P

    更新日期:2017-04-01 00:00:00

  • The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cells.

    abstract::The microenvironment of glioblastoma (GBM) contains high levels of inflammatory cytokine interleukin 6 (IL-6), which contributes to promote tumour progression and invasion. The common epidermal growth factor receptor variant III (EGFRvIII) mutation in GBM is associated with significantly higher levels of IL-6. Further...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.225

    authors: Gurgis FM,Yeung YT,Tang MX,Heng B,Buckland M,Ammit AJ,Haapasalo J,Haapasalo H,Guillemin GJ,Grewal T,Munoz L

    更新日期:2015-05-28 00:00:00

  • Repression of cancer cell senescence by PKCι.

    abstract::Senescence is an irreversible growth arrest phenotype adopted by cells that has a key role in protecting organisms from cancer. There is now considerable interest in therapeutic strategies that reactivate this process to control the growth of cancer cells. Protein kinase-Cι (PKCι) is a member of the atypical PKC famil...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.524

    authors: Paget JA,Restall IJ,Daneshmand M,Mersereau JA,Simard MA,Parolin DA,Lavictoire SJ,Amin MS,Islam S,Lorimer IA

    更新日期:2012-08-02 00:00:00

  • GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.

    abstract::Intraductal papillary mucinous neoplasm (IPMN), the most common pancreatic cystic neoplasm, is known to progress to invasive ductal adenocarcinoma. IPMNs commonly harbor activating somatic mutations in GNAS and KRAS, primarily GNAS(R201H) and KRAS(G12D). GNAS encodes the stimulatory G-protein α subunit (Gsα) that medi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.294

    authors: Taki K,Ohmuraya M,Tanji E,Komatsu H,Hashimoto D,Semba K,Araki K,Kawaguchi Y,Baba H,Furukawa T

    更新日期:2016-05-05 00:00:00

  • Human INT6 interacts with MCM7 and regulates its stability during S phase of the cell cycle.

    abstract::The mouse int6 gene is a frequent integration site of the mouse mammary tumor virus and INT6 silencing by RNA interference in HeLa cells causes an increased number of cells in the G2/M phases of the cell cycle, along with mitotic defects. In this report, we investigated the functional significance of the interaction b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210314

    authors: Buchsbaum S,Morris C,Bochard V,Jalinot P

    更新日期:2007-08-02 00:00:00

  • Wild-type egr1/Krox24 promotes and dominant-negative mutants inhibit, pluripotent differentiation of p19 embryonal carcinoma cells.

    abstract::The zinc-finger transcription factor Krox24 was analysed for its role in differentiation in P19 embryonal carcinoma cells. Reciprocal dominant negative mutants consisting of Krox24 deleted for a crucial region of the zinc-finger domain (delta Krox24) or of the zinc-finger region alone (delta Krox24Zf) abolished the ac...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202166

    authors: Lanoix J,Mullick A,He Y,Bravo R,Skup D

    更新日期:1998-11-12 00:00:00

  • Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer.

    abstract::Oxygen is the ultimate source of oxidizing power for disulfide bond formation, suggesting that under limiting oxygen proper protein folding might be compromised. We show that secretion of vascular endothelial growth factor (VEGF), a protein with multiple disulfide bonds, was indeed impeded under hypoxia and was partia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208325

    authors: May D,Itin A,Gal O,Kalinski H,Feinstein E,Keshet E

    更新日期:2005-02-03 00:00:00

  • Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene.

    abstract::We have isolated a candidate tumor suppressor gene from a 600-kb region on chromosome 8p21.3-p22 that is commonly deleted in sporadic hepatocellular carcinomas (HCC), colorectal cancers (CRC), and non-small cell lung cancers (NSCLC). As this gene encodes a protein of 375 amino acids that bears significant sequence sim...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Fujiwara Y,Ohata H,Kuroki T,Koyama K,Tsuchiya E,Monden M,Nakamura Y

    更新日期:1995-03-02 00:00:00

  • Disruption of ATM in p53-null cells causes multiple functional abnormalities in cellular response to ionizing radiation.

    abstract::ATM is a member of the large phosphatidylinositol-3 kinase family and plays an important role in cellular response to DNA damage. To further define the physiological roles of ATM at the cellular level, we created an isogenic set of stable cell lines differing only in their ATM status from the chicken B cell line DT40 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203172

    authors: Takao N,Kato H,Mori R,Morrison C,Sonada E,Sun X,Shimizu H,Yoshioka K,Takeda S,Yamamoto K

    更新日期:1999-11-25 00:00:00

  • Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.

    abstract::Among surface molecules expressed on endothelial cells, endoglin (CD105) is emerging as a prime vascular target for antiangiogenetic cancer therapy. CD105 is a cell membrane glycoprotein mainly expressed on endothelial cells and overexpressed on tumor-associated vascular endothelium, which functions as an accessory co...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206813

    authors: Fonsatti E,Altomonte M,Nicotra MR,Natali PG,Maio M

    更新日期:2003-09-29 00:00:00

  • SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.

    abstract::Liver metastasis remains a serious problem in the management of gastric cancer (GC). Our aims were to identify through transcriptome analysis a molecule that mediates hepatic metastasis in GC, and to evaluate its potential as a diagnostic marker and a therapeutic target. The effects of knocking out a relevant molecule...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0335-8

    authors: Kanda M,Tanaka H,Shimizu D,Miwa T,Umeda S,Tanaka C,Kobayashi D,Hattori N,Suenaga M,Hayashi M,Iwata N,Yamada S,Fujiwara M,Kodera Y

    更新日期:2018-09-01 00:00:00

  • α-Catulin knockdown induces senescence in cancer cells.

    abstract::Cellular senescence functions as a tumor suppressor that protects against cancer progression. α-Catulin, an α-catenin-related protein, is reported to have tumorigenic potential because it regulates the nuclear factor-κB (NF-κB) pathway, but little is known about its clinical relevance and the mechanism through which i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.637

    authors: Fan LC,Chiang WF,Liang CH,Tsai YT,Wong TY,Chen KC,Hong TM,Chen YL

    更新日期:2011-06-09 00:00:00

  • Notch-induced mammary tumorigenesis does not involve the lobule-limited epithelial progenitor.

    abstract::The mouse mammary epithelial cell hierarchy contains both multipotent stem cell as well as lineage-limited duct and lobular progenitor cell functions. The latter-also termed parity-identified mammary epithelial cells (PI-MECs)-are marked by beta-galactosidase (β Gal) expression following pregnancy and involution in wh...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.215

    authors: Bruno RD,Boulanger CA,Smith GH

    更新日期:2012-01-05 00:00:00

  • Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells.

    abstract::Activation of the Met tyrosine kinase growth factor receptor by its ligand HGF/SF has been shown to increase in vitro invasiveness in epithelial cell lines. To study the effect of Met-HGF/SF signaling in breast cancer cells, we transfected met, hgf/sf and dominant negative (DN) forms of met into the poorly differentia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203557

    authors: Firon M,Shaharabany M,Altstock RT,Horev J,Abramovici A,Resau JH,Vande Woude GF,Tsarfaty I

    更新日期:2000-05-11 00:00:00

  • Functional capabilities of molecular network components controlling the mammalian G1/S cell cycle phase transition.

    abstract::The molecular interactions implicated in the mammalian G1/S cell cycle phase transition comprise a highly nonlinear network which can produce seemingly paradoxical results and make intuitive interpretations unreliable. A new approach to this problem is presented, consisting of (1) a convention of unambiguous reaction ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201608

    authors: Kohn KW

    更新日期:1998-02-26 00:00:00

  • Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.

    abstract::The hypoxia-inducible factor 1 (HIF-1) plays a critical role for tumour adaptation to microenvironmental hypoxia, and represents an appealing chemotherapeutic target. Silibinin is a nontoxic flavonoid reported to exhibit anticancer properties. However, the mechanisms by which silibinin inhibits tumour growth are not f...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.398

    authors: García-Maceira P,Mateo J

    更新日期:2009-01-22 00:00:00

  • Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.

    abstract::ID4 gene is a member of the inhibitor of DNA-binding (ID) family, which inhibits DNA binding of basic helix-loop-helix transcription factors. Certain human primary breast cancers reportedly have low or no expression of ID4 protein, but its role in carcinogenesis and cancer progression is unknown. To determine its poss...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208538

    authors: Umetani N,Mori T,Koyanagi K,Shinozaki M,Kim J,Giuliano AE,Hoon DS

    更新日期:2005-07-07 00:00:00

  • Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.

    abstract::Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome that includes pheochromocytoma. Germline mutations in RET are responsible for MEN 2 but the precise pathogenetic mechanisms of tumorigenesis are unknown. We have recently identified possible mechanisms of tumor formation in patients with MEN 2...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205133

    authors: Koch CA,Huang SC,Zhuang Z,Stolle C,Azumi N,Chrousos GP,Vortmeyer AO,Pacak K

    更新日期:2002-01-17 00:00:00

  • Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1.

    abstract::Alpha-fetoprotein (AFP) producing gastric cancer (AFP-GC) is very malignant and highly metastatic compared with common gastric cancer. However, the causal relationship between AFP production and the high malignancy of AFP-GC is unclear. We investigated AFP gene regulation in AFP-GC by an active transcription factor, H...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204160

    authors: Kataoka H,Miura Y,Joh T,Seno K,Tada T,Tamaoki T,Nakabayashi H,Kawaguchi M,Asai K,Kato T,Itoh M

    更新日期:2001-02-15 00:00:00

  • Characterization of changes in gene expression associated with malignant transformation by the NF-kappaB family member, v-Rel.

    abstract::In this study, alterations in gene expression patterns have been examined in v-Rel-transformed avian bone marrow cells. Using a conditional v-Rel estrogen receptor chimera (v-RelER) which transforms cells in an estrogen-dependent manner, we constructed subtraction cDNA libraries from v-RelER-transformed bone marrow ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201334

    authors: Petrenko O,Ischenko I,Enrietto PJ

    更新日期:1997-10-02 00:00:00

  • Decreased intranuclear mobility of acute myeloid leukemia 1-containing fusion proteins is accompanied by reduced mobility and compartmentalization of core binding factor beta.

    abstract::Acute myeloid leukemia 1 (AML1) gene on chromosome 21 is involved in several chromosomal translocations, including t(8;21) and t(16;21), that produce chimeric fusion proteins AML1-eight twenty-one (ETO) and AML-myeloid transforming gene chromosome 16 (MTG16), which contribute to leukemogenesis. The molecular basis for...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209431

    authors: Qiu J,Wong J,Tweardy DJ,Dong S

    更新日期:2006-06-29 00:00:00

  • Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation.

    abstract::Maspin has been demonstrated to be a suppressor of invasion and cell motility in vitro, whereas in vivo analyses have reported that increased expression of maspin is associated with malignant behavior. The present study examined maspin expression in normal lung and non-small-cell lung cancers. Only proximal airway cel...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207557

    authors: Yatabe Y,Mitsudomi T,Takahashi T

    更新日期:2004-05-20 00:00:00

  • Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.

    abstract::Caspase-8 is a key effector of death-receptor-triggered apoptosis. In a previous study, we demonstrated, however, that caspase-8 can also be activated in a death receptor-independent manner via the mitochondrial apoptosis pathway, downstream of caspase-3. Here, we show that caspases-3 and -8 mediate a mitochondrial am...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206280

    authors: von Haefen C,Wieder T,Essmann F,Schulze-Osthoff K,Dörken B,Daniel PT

    更新日期:2003-04-17 00:00:00

  • PTEN functions as a melanoma tumor suppressor by promoting host immune response.

    abstract::Cancer cells acquire several traits that allow for their survival and progression, including the ability to evade the host immune response. However, the mechanisms by which cancer cells evade host immune responses remain largely elusive. Here we study the phenomena of immune evasion in malignant melanoma cells. We fin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.409

    authors: Dong Y,Richards JA,Gupta R,Aung PP,Emley A,Kluger Y,Dogra SK,Mahalingam M,Wajapeyee N

    更新日期:2014-09-18 00:00:00

  • HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma.

    abstract::Transcription factor PAX8 expression is upregulated in several types of cancers. However, little is known about the function of PAX8 in the progression of hepatoma and its regulatory mechanisms. Here, we show that PAX8 silencing inhibits the proliferation and clonogenicity of hepatoma cells and its growth in vivo. The...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0907-2

    authors: Wang J,Li N,Huang ZB,Fu S,Yu SM,Fu YM,Zhou PC,Chen RC,Zhou RR,Huang Y,Hu XW,Fan XG

    更新日期:2019-10-01 00:00:00

  • The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization.

    abstract::ASPP1 and ASPP2 are both proteins that interact with p53 and enhance its ability to induce apoptosis by selectively elevating the expression of proapoptotic p53-responsive genes. iASPP(RAI) is a third member of the family that is the most conserved inhibitor of p53-mediated apoptosis. Here, we have described iASPP, a ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208088

    authors: Slee EA,Gillotin S,Bergamaschi D,Royer C,Llanos S,Ali S,Jin B,Trigiante G,Lu X

    更新日期:2004-12-02 00:00:00

  • Alternate mechanisms of ras activation are complementary and favor and formation of ras-GTP.

    abstract::The mechanisms of ras activation by mutations in residue 61 and in the NKXD guanine nucleotide-binding consensus sequence (ras residues 116-119) have been evaluated. Weakly transforming mutations that either reduce intrinsic and GTPase-activating protein (GAP)-stimulated GTPase activities (61P) or enhance guanine nucl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Patel G,MacDonald MJ,Khosravi-Far R,Hisaka MM,Der CJ

    更新日期:1992-02-01 00:00:00

  • The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.

    abstract::The role of TGF-β signaling in tumorigenesis is paradoxical: it can be tumor suppressive or tumor promotional, depending on context. The metastatic regulator, Six1, was recently shown to mediate this switch, providing a novel means to explain this elusive 'TGF-β paradox'. Herein, we identify a mechanism by which Six1 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.11

    authors: Smith AL,Iwanaga R,Drasin DJ,Micalizzi DS,Vartuli RL,Tan AC,Ford HL

    更新日期:2012-12-13 00:00:00